{"id":"https://openalex.org/W2215767719","doi":null,"title":"Novel pharmacological approaches to the treatment of schizophrenia.","display_name":"Novel pharmacological approaches to the treatment of schizophrenia.","publication_year":2000,"publication_date":"2000-06-01","ids":{"openalex":"https://openalex.org/W2215767719","mag":"2215767719","pmid":"https://pubmed.ncbi.nlm.nih.gov/10913983"},"language":"en","primary_location":{"id":"pmid:10913983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10913983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Danish medical bulletin","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001609083","display_name":"Anders Fink\u2010Jensen","orcid":"https://orcid.org/0000-0001-7143-1236","observed_orcids":["https://orcid.org/0000-0001-7143-1236"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"A Fink-Jensen","raw_affiliation_strings":["Novo Nordisk A/S, Copenhagen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Copenhagen","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5001609083"],"corresponding_institution_ids":["https://openalex.org/I189090001"],"apc_list":null,"apc_paid":null,"fwci":0.6303,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.71947195,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"47","issue":"3","first_page":"151","last_page":"67"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9020000100135803},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8970000147819519},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9629999995231628},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/fos-protein","display_name":"Fos protein","score":0.7419999837875366},{"id":"https://openalex.org/keywords/neuronal-activity","display_name":"neuronal activity","score":0.5799999833106995},{"id":"https://openalex.org/keywords/medial-prefrontal-cortex","display_name":"medial prefrontal cortex","score":0.8460000157356262},{"id":"https://openalex.org/keywords/dorsolateral-striatum","display_name":"dorsolateral striatum","score":0.9200000166893005},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dopaminergic-tone","display_name":"dopaminergic tone","score":0.7839999794960022},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.8769999742507935},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.9100000262260437},{"id":"https://openalex.org/keywords/motor-side-effects","display_name":"motor side effects","score":0.7080000042915344},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.8339999914169312},{"id":"https://openalex.org/keywords/sertindole","display_name":"sertindole","score":0.9879999756813049},{"id":"https://openalex.org/keywords/neuroleptic-induced-parkinsonism","display_name":"neuroleptic-induced parkinsonism","score":0.4860000014305115},{"id":"https://openalex.org/keywords/neuroleptic-induced-akathisia","display_name":"neuroleptic-induced akathisia","score":0.7089999914169312},{"id":"https://openalex.org/keywords/neuroleptic-induced-tardive-dyskinesia","display_name":"neuroleptic-induced tardive dyskinesia","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7620446681976318},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6708599328994751},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6636133790016174},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.6269580721855164},{"id":"https://openalex.org/C2781195155","wikidata":"https://www.wikidata.org/wiki/Q18680","display_name":"Prefrontal cortex","level":3,"score":0.6234682202339172},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.6073673367500305},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5815442204475403},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.5814927220344543},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.47652968764305115},{"id":"https://openalex.org/C2776509080","wikidata":"https://www.wikidata.org/wiki/Q309406","display_name":"Apathy","level":3,"score":0.4662524461746216},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4573691487312317},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.4495686888694763},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.442862868309021},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4162607789039612},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3887549042701721},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.3009437918663025},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2949339747428894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.203495055437088}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016762","descriptor_name":"Genes, fos","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016762","descriptor_name":"Genes, fos","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10913983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10913983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Danish medical bulletin","raw_type":"Journal Article"},{"id":"mag:2215767719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10913983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2095859836","https://openalex.org/W15882601","https://openalex.org/W2151331628","https://openalex.org/W2075740595","https://openalex.org/W2115828077","https://openalex.org/W2134029180","https://openalex.org/W15308039","https://openalex.org/W2060661060","https://openalex.org/W2130803132","https://openalex.org/W2920469301"],"abstract_inverted_index":{"Schizophrenia":[0],"is":[1,81,110,115,152,250],"a":[2,83,97,118,253,353,365,551],"devastating":[3],"mental":[4],"disease":[5],"that":[6,112,145,513],"affects":[7],"the":[8,19,32,39,66,74,77,123,129,155,169,193,203,216,219,224,233,240,244,268,276,283,290,298,306,318,326,336,342,386,418,439,444,454,471,474,500,511,518,523,539],"human":[9],"population":[10],"worldwide":[11],"with":[12,51,117,189,320,338,385,422,499],"an":[13],"incidence":[14],"of":[15,31,34,41,43,76,92,100,132,172,196,206,218,243,255,263,279,293,310,390,398,404,443,453,503,526],"about":[16],"1%.":[17],"Over":[18],"last":[20],"decades":[21],"basic":[22],"and":[23,47,57,79,137,163,174,181,223,258,295,349,374,393,400,463,480,507,509,543],"clinical":[24,501],"research":[25],"has":[26,141],"considerably":[27],"increased":[28,146,468,486],"our":[29,212],"understanding":[30],"pathophysiology":[33],"schizophrenia,":[35,133,280],"as":[36,38,135,161,252],"well":[37],"mechanism":[40],"action":[42],"antipsychotic":[44,55,89,447],"compounds":[45,363,448],"(neuroleptics),":[46],"new":[48,199],"atypical":[49,175,225,345,362,475],"neuroleptics":[50,176,346,412,531],"equipotent":[52],"or":[53,322],"improved":[54],"effects":[56,61,171,195,217,309,324,389,407,442,502],"fewer":[58],"motoric":[59,307,405],"side":[60,308,406],"have":[62,95],"been":[63,143],"developed.":[64],"However,":[65],"pharmacological":[67,194,200],"intervention":[68],"does":[69],"not":[70],"effectively":[71],"treat":[72],"all":[73],"symptoms":[75,131,278,292,397,429,525],"disease,":[78],"there":[80],"still":[82],"need":[84],"for":[85,192,378],"new,":[86],"more":[87],"effective":[88],"compounds.":[90],"Studies":[91],"brain":[93,187],"function":[94],"demonstrated":[96],"reduced":[98,119,514],"activation":[99],"prefrontal":[101,124,270,519],"cortical":[102],"areas":[103,151,188],"during":[104],"cognitive":[105],"tasks":[106],"in":[107,122,149,184,232,267,275,282,289,297,305,317,325,335,341,372,383,417,420,430,460,470,488,497,517],"schizophrenics.":[108,431],"It":[109,140],"hypothesized,":[111],"this":[113],"hypofrontality":[114],"associated":[116],"dopaminergic":[120,147,182,441,515],"tonus":[121,183],"cortex,":[125],"which":[126,537],"subsequently":[127],"causes":[128],"negative":[130,277,396,524],"such":[134,160],"apathy":[136],"social":[138],"withdraw.":[139],"also":[142],"suggested,":[144],"activity":[148,180,231,257],"striatal":[150],"related":[153],"to":[154,202,409,425,437,484,491,522],"wellknown":[156],"positive":[157,291,427],"schizophrenic":[158],"symptoms,":[159],"delusions":[162],"hallucinations.":[164],"The":[165,247,361,432,547],"present":[166,548],"thesis":[167,549],"addresses":[168],"regional":[170,241,440],"prototypical":[173,220],"on":[177,211,228,395],"nerve":[178,229],"cell":[179,230],"three":[185],"rat":[186,234],"special":[190],"relevance":[191],"neuroleptics.":[197,311],"Finally,":[198],"approaches":[201],"medical":[204],"treatment":[205],"schizophrenia":[207,294,399],"are":[208,382,496],"suggested":[209],"based":[210],"experimental":[213],"results.":[214],"Initially,":[215],"neuroleptic":[221,226],"haloperidol":[222,330,508],"clozapine":[227],"forebrain":[235],"were":[236],"investigated":[237],"by":[238,261,449],"measuring":[239,450],"expression":[242,356,371],"Fos":[245,248,314,332,354,369,414],"protein.":[246],"protein":[249,315,333,355,370,415],"regarded":[251],"marker":[254],"cellular":[256],"was":[259,435],"measured":[260,377],"use":[262],"immunohistochemical":[264],"techniques":[265],"i)":[266],"medial":[269],"cortex":[271,520],"(PFC),":[272],"probably":[273,287],"involved":[274,288,304],"ii)":[281],"nucleus":[284],"accumbens":[285],"(NAc),":[286],"iii)":[296],"dorsolateral":[299],"striatum":[300],"(DLSt),":[301],"most":[302],"likely":[303],"Clozapine":[312],"increases":[313,331],"immunoreactivity":[316,334,416],"PFC":[319,373,489],"no":[321],"minimal":[323],"DLSt.":[327,464,492],"In":[328],"contrast,":[329],"DLSt":[337,375],"minor":[339],"effect":[340],"PFC.":[343],"Other":[344],"(risperidone,":[347],"sertindole":[348,394,479,506],"NNC":[350,481],"22-0031)":[351],"induced":[352,413],"pattern":[357],"different":[358],"from":[359],"haloperidol:":[360],"exhibit":[364],"larger":[366],"ratio":[367],"between":[368],"than":[376],"haloperidol.":[379,410],"These":[380],"results":[381,495],"accordance":[384,421],"reported":[387],"beneficial":[388],"clozapine,":[391,477,504],"risperidone":[392],"their":[401,423],"lower":[402],"degree":[403],"compared":[408,490],"All":[411,465,528],"NAc,":[419,472],"ability":[424],"reduce":[426],"psychotic":[428],"microdialysis":[433],"technique":[434],"used":[436],"investigate":[438],"above":[445],"mentioned":[446],"interstitial":[451],"levels":[452],"dopamine":[455,534,540,552],"metabolite":[456],"dihydroxyphenylacetic":[457],"acid":[458],"([DOPAC]i)":[459],"PFC,":[461],"NAc":[462],"antipsychotics":[466,476],"tested":[467],"[DOPAC]i":[469,487],"whereas":[473],"risperidone,":[478,505],"22-0031--in":[482],"contrast":[483],"haloperidol--preferentially":[485],"Also":[493],"these":[494],"concordance":[498],"support":[510],"hypothesis":[512],"tone":[516],"relates":[521],"schizophrenia.":[527],"clinically":[529],"efficacious":[530],"block":[532],"central":[533],"D2":[535],"receptors,":[536],"include":[538],"D2,":[541],"D3":[542,553],"D4":[544],"receptor":[545,554],"subtypes.":[546],"characterizes":[550],"agonist,":[555],"cis-OH-PBZI.":[556]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}